[CAPN] Capnia, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 0.81 Change: 0.08 (10.96%)
Ext. hours: Change: 0 (0%)

chart CAPN

Refresh chart

Description: Capnia, Inc. develops and commercializes therapeutics and diagnostics products. The company offers CoSense for the diagnosis of excessive hemolysis in neonates, a condition that causes long-term developmental disability due to degradation of red blood cells. It also develops Serenz, a therapeutic product candidate that has completed Phase II clinical trials for the treatment of symptoms related to allergic rhinitis. The company was founded in 1999 and is based in Redwood City, California.

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding EPS-1.02 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters Sales Growth - Q/Q P/E-0.69
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-245.28% ROE218.46% ROI
Current Ratio9.46 Quick Ratio Long Term Debt/Equity Debt Ratio-0.09
Gross Margin Operating Margin Net Profit Margin Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities3.38 M Cash From Investing Activities Cash From Operating Activities-1.81 M Gross Profit
Net Profit-11.65 M Operating Profit-2.43 M Total Assets10.07 M Total Current Assets10.02 M
Total Current Liabilities1.06 M Total Debt Total Liabilities21.37 M Total Revenue20 K
Technical Data
High 52 week1.36 Low 52 week0.56 Last close0.7 Last change0%
RSI76.34 Average true range0.28 Beta0.42 Volume221.54 K
Simple moving average 20 days8.59% Simple moving average 50 days6.07% Simple moving average 200 days-17.27%
Performance Data
Performance Week0% Performance Month18.64% Performance Quart-14.63% Performance Half-27.2%
Performance Year-35.79% Performance Year-to-date-13.58% Volatility daily3.18% Volatility weekly7.11%
Volatility monthly14.57% Volatility yearly50.46% Relative Volume418.43% Average Volume48.1 K
New High New Low

News

2017-07-24 16:05:00 | Soleno Therapeutics Announces Sale of Non-Strategic Assets to Flexicare, Inc.

2017-07-05 08:00:00 | Soleno Therapeutics Announces Successful Completion of FDA Meeting for DCCR in Prader-Willi Syndrome

2017-05-11 16:05:00 | Capnia Provides Corporate Update and Reports First Quarter 2017 Financial Results

2017-03-20 11:51:22 | CAPNIA, Inc. :CAPN-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017

2017-03-17 10:08:51 | CAPNIA, Inc. :CAPN-US: Earnings Analysis: 2016 By the Numbers : March 17, 2017

2017-03-15 16:23:22 | CAPNIA, INC. Files SEC form 10-K, Annual Report

2017-03-15 16:10:53 | Capnia Reports Fourth Quarter and Full Year 2016 Financial Results

2017-03-08 16:45:18 | CAPNIA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition

2017-03-08 07:00:00 | Capnia Completes Merger with Essentialis Creating Rare Disease Therapeutics Company

2017-03-08 07:00:00 | Capnia Completes Merger with Essentialis Creating Rare Disease Therapeutics Company

2017-02-28 18:20:07 | CAPNIA, INC. Files SEC form 8-K, Other Events

2017-02-07 07:00:00 | Capnia to Present at the 19th Annual BIO CEO & Investor Conference

2017-01-09 06:04:29 | CAPNIA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits

2017-01-03 17:26:39 | CAPNIA, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

2016-12-27 16:09:12 | CAPNIA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities,

2016-12-27 09:32:05 | Capnia and Essentialis Announce Merger to Create Rare Disease Therapeutics Company

2016-12-27 09:00:21 | Capnia Inc. shares halted on news of merger agreement with privately-held Essentialis Inc.

2016-12-27 08:46:00 | 8:46 am Capnia and privately-held Essentialis announce a merger to create rare disease therapeutics company shares halted

2016-12-27 08:45:00 | Capnia and Essentialis Announce Merger to Create Rare Disease Therapeutics Company

2016-11-23 11:39:07 | Capnia downgraded by Maxim Group

2016-11-18 11:13:09 | CAPNIA, Inc. :CAPN-US: Earnings Analysis: Q3, 2016 By the Numbers : November 18, 2016

2016-11-14 17:55:09 | CAPNIA, INC. Files SEC form 10-Q, Quarterly Report

2016-11-14 16:17:14 | Capnia Reports Third Quarter 2016 Financial Results

2016-11-14 16:05:00 | Capnia Reports Third Quarter 2016 Financial Results

2016-10-26 17:02:53 | CAPNIA, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Tran

2016-09-06 09:19:10 | Capnia to Present at Upcoming Investor Conferences

2016-09-06 07:00:00 | Capnia to Present at Upcoming Investor Conferences

2016-08-20 13:04:22 | CAPNIA, INC. Financials

2016-08-16 10:26:05 | CAPNIA, Inc. :CAPN-US: Earnings Analysis: Q2, 2016 By the Numbers : August 16, 2016

2016-08-12 17:09:05 | CAPNIA, INC. Files SEC form 10-Q, Quarterly Report

2016-08-12 16:21:07 | Capnia Reports Second Quarter 2016 Financial Results

2016-08-12 16:05:00 | Capnia Reports Second Quarter 2016 Financial Results

2016-08-09 16:45:07 | CAPNIA, INC. Files SEC form 10-Q/A, Quarterly Report

2016-08-04 06:09:57 | CAPNIA, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders

2016-07-06 16:51:27 | CAPNIA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities,

2016-06-29 19:21:03 | Capnia Announces Private Placement of Up to $13.8 Million of Convertible Preferred Stock

2016-06-15 07:19:07 | Capnia Expands Commercial Launch of Serenz® Allergy Relief to Ireland

2016-06-14 16:04:56 | CAPNIA, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders

2016-06-07 16:18:03 | Capnia Announces Exclusive Distribution Agreement for CoSense® End-Tidal Carbon Monoxide Monitor in India

2016-06-01 14:03:20 | CAPNIA, Inc. :CAPN-US: Earnings Analysis: Q1, 2016 By the Numbers : June 1, 2016

2016-05-25 16:26:07 | Capnia to Present at 2016 Marcum MicroCap Conference

2016-05-12 17:38:34 | CAPNIA, INC. Files SEC form 10-Q, Quarterly Report

2016-05-10 09:48:09 | Capnia Reports First Quarter 2016 Financial Results

2016-04-27 16:27:40 | Capnia to Present at the Joseph Gunnar “Pioneers 2016” Conference

2016-04-26 07:06:26 | Capnia Commences Serenz® Allergy Relief Product Sales in Europe

2016-04-21 16:44:43 | CAPNIA, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits

2016-04-20 07:10:55 | Capnia Announces Presentation of CoSense® and Other Pipeline Candidate Data at the 2016 Pediatric Academic Societies Annual Meeting

2016-04-18 07:21:26 | Capnia Names Rajen Dalal to Board of Directors

2016-03-31 16:06:03 | CAPNIA, INC. Files SEC form 8-K, Change in Directors or Principal Officers

2016-03-25 16:35:37 | CAPNIA, INC. Files SEC form 10-K, Annual Report